Skip to main content

Peer Review reports

From: Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis

Original Submission
15 Jul 2018 Submitted Original manuscript
2 Aug 2018 Reviewed Reviewer Report - Adriani Nikolakopoulou
24 Sep 2018 Reviewed Reviewer Report - Doreen Allen Kahangire
11 Oct 2018 Author responded Author comments - Florence Wilson
Resubmission - Version 2
11 Oct 2018 Submitted Manuscript version 2
18 Oct 2018 Reviewed Reviewer Report - Adriani Nikolakopoulou
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
23 Oct 2018 Editorially accepted
14 Nov 2018 Article published 10.1186/s13643-018-0854-y

You can find further information about peer review here.

Back to article page